Udtog, Noraisa .
HRN: 23-32-03 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/09/2023
CO-AMOXICLAV 625MG (TAB)
08/09/2023
08/16/2023
ORAL
625
BID
RMLE
Checking Final Appropriateness